You are here: Home » PTI Stories » National » News
Business Standard

Cipla launches Niveoli inhaler in India

Press Trust of India  |  New Delhi 

Drug Friday announced the launch of its proprietary product 'Niveoli' in

is used in respiratory that addresses an unmet need associated with (OAD) such as and (COPD), said in a BSE filing.

said Niveoli, extra-fine particle beclomethasone-combination hydrofluoroalkane (HFA) for adults, targets to the small airways.

"We see our market leadership as well as the range and depth of our R&D and in this therapy as a privilege and a responsibility to do more for patients," Cipla Head - business said.

Shares of Cipla were trading 0.40 per cent higher at Rs 546.55 apiece on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, April 12 2019. 10:30 IST